Zota Health Care FY26 Revenue Soars 83.86% to ₹53,865.75 Lakhs; Davaindia Stores Reach 2,579
Zota Health Care reported FY26 consolidated revenue growth of 83.86% to ₹53,865.75 lakhs and a 108.57% increase in Gross Profit to ₹32,468.90 lakhs. The Davaindia network expanded to 2,579 stores. The company launched 'All Day Stores' and appointed Akshay Kumar as brand ambassador.
The substantial revenue growth, expansion of retail footprint, and strategic initiatives like new store formats and brand ambassadorship are likely to have a significant positive impact on the company's market position and future performance.
The company reported strong year-on-year growth in revenue and gross profit, significant expansion of its store network, and strategic new launches and brand ambassador appointments.
Zota Health Care Limited announced its audited financial results for the fourth quarter and full year ended March 31, 2026. The company reported a significant year-on-year growth in consolidated revenue from operations, which stood at ₹53,865.75 lakhs in FY26, marking an 83.86% increase compared to ₹29,297.48 lakhs in FY25.
Consolidated Gross Profit also saw a substantial rise of 108.57% to ₹32,468.90 lakhs in FY26 from ₹15,567.13 lakhs in FY25, with Gross Margin expanding by 714 basis points to 60.28%. Consolidated EBITDA for FY26 was reported at ₹2,597.73 lakhs.
Operationally, Zota Health Care expanded its Davaindia network significantly, adding 997 new stores in FY26, resulting in a total of 2,579 stores nationwide. This expansion included 804 COCO and 193 FOFO stores added during the fiscal year. The company also appointed Mr. Akshay Kumar as the brand ambassador for its “UGO Generic” platform, aiming to deliver affordable medicines across India.
Furthermore, Zota launched a new retail format, “All Day Stores” (ADS), under its subsidiary Everyday Herbal Beauty Care Limited (EHBCL), offering a wide portfolio of private label products. The company also increased its stake in EHBCL to 87.78% by investing ₹19.47 crore through a rights issue.
Commenting on the performance, Chairman Mr. Ketan Kumar Zota highlighted the strong execution and expansion, the successful completion of a ₹350 crore QIP, and the strategic investments. He expressed optimism for FY27, with a long-term vision to reach 5,000 Davaindia stores by FY29.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.